Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Radhika MISHRA"'
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-17 (2023)
Abstract Background Immune checkpoint blockade (ICB) elicits a strong and durable therapeutic response, but its application is limited by disparate responses and its associated immune-related adverse events (irAEs). Previously, in a murine model of l
Externí odkaz:
https://doaj.org/article/a609b0ec6f3c4b7d9da4191c4698a9af
Autor:
Honoka Fujii, Sachiko Horie, Ariunbuyan Sukhbaatar, Radhika Mishra, Maya Sakamoto, Shiro Mori, Tetsuya Kodama
Publikováno v:
Cancer Medicine, Vol 8, Iss 5, Pp 2241-2251 (2019)
Abstract Metastatic lymph nodes (LNs) may be the origin of systemic metastases. It will be important to develop a strategy that prevents systemic metastasis by treating these LNs at an early stage. False‐negative metastatic LNs, which are found dur
Externí odkaz:
https://doaj.org/article/a1d7fa00aadc4141842df6d174928399
Autor:
Radhika Mishra, Ariunbuyan Sukhbaatar, Arunkumar Dorai, Shiro Mori, Kiyoto Shiga, Tetsuya Kodama
Publikováno v:
Cancer Science. 114:259-270
Treatment of metastatic lymph nodes (LNs) is challenging due to their unique architecture and biophysical traits. Systemic chemotherapy fails to impede tumor progression in LNs due to poor drug uptake and retention by LNs, resulting in fatal systemic
Publikováno v:
International Journal of Physical Education, Sports and Health. 10:96-98
Publikováno v:
International Journal of Physical Education, Sports and Health. 9:310-312
Autor:
Tetsuya Kodama, Radhika Mishra, Maya Sakamoto, Ryoichi Fukumura, Shiro Mori, Ariunbuyan Sukhbaatar
Publikováno v:
Cancer Science
Lymph node (LN) metastasis is thought to account for 20‐30% of deaths from head and neck cancer. The lymphatic drug delivery system (LDDS) is a new technology that enables the injection of drugs into a sentinel LN (SLN) during the early stage of tu
Publikováno v:
Cancer Prevention Research. 16:P046-P046
Background: Metastasis is the prime cause of cancer associated mortality. Lymph nodes (LNs) facilitate the systemic exposure of tumor cells, resulting in fatal systemic metastasis. Treatment of metastatic LNs is therefore imperative. However, success
Autor:
Shiro Mori, Ariunbuyan Sukhbaatar, Ryoichi Kikuchi, Maya Sakamoto, Tetsuya Kodama, Radhika Mishra, Teppei Yamaki
Publikováno v:
Clinicalexperimental metastasis. 38(6)
A perfusion defect in a metastatic lymph node (LN) can be visualized as a localized area of low contrast on contrast-enhanced CT, MRI or ultrasound images. Hypotheses for perfusion defects include abnormal hemodynamics in neovascular vessels or a dec
Autor:
Tetsuya Kodama, Shiro Mori, Ariunbuyan Sukhbaatar, Maya Sakamoto, Radhika Mishra, Honoka Fujii, Sachiko Horie
Publikováno v:
Cancer Medicine, Vol 8, Iss 5, Pp 2241-2251 (2019)
Cancer Medicine
Cancer Medicine
Metastatic lymph nodes (LNs) may be the origin of systemic metastases. It will be important to develop a strategy that prevents systemic metastasis by treating these LNs at an early stage. False‐negative metastatic LNs, which are found during the e
Autor:
Miriu MIYTATSU, Koki TAKAGI, Shizuki KURIU, Ariunbuyan SUKHBAATAR, Radhika MISHRA, Daiki NAGAMATSU, Kenta SUZUKI, Shiro MORI, Maya SAKAMOTO, Tetsuya KODAMA
Publikováno v:
The Proceedings of the JSME Conference on Frontiers in Bioengineering. :1C27